浙江医药

600216 SSE 证监会行业分类 C27医药制造业

Key Metrics

Market Cap

14.6B ($2.1B)

P/E Ratio

N/A

P/B Ratio

N/A

Revenue

9.4B

Net Income

1.0B

Gross Margin

N/A

Op. Margin

13.0%

Net Margin

10.9%

ROE

9.4%

ROA

7.4%

D/E

0.27

Dividend Yield

N/A

EPS

1.21

Current Ratio

2.56

Price History

Company Info

Industry	C27医药制造业
Market Segment	Main Board
Currency	CNY
Fiscal Year	2024

Business Overview

Zhejiang Medicine Co., Ltd. manufactures and sells life nutrition and medical products in China and internationally. The company offers synthetic vitamin E, natural vitamin E, ß-carotene, cantharidin, vancomycin hydrochloride, and teicoplanin. It also provides fat-soluble vitamins, retinoids, quinolone antibiotics, anti-resistance antibiotics, and other products, as well as animal nutrition products. In addition, the company offers injectable levofloxacin lactate, injectable vancomycin hydrochloride injections, and injectable teicoplanin products. The company was incorporated in 1997 and is ba...

Full Financials Advanced Charts Filings

Peers

工商银行

601398

2.7T

P/E: 7.6

建设银行

601939

2.5T

P/E: 7.2

农业银行

601288

2.4T

P/E: 8.7

中国海油

600938

2.0T

P/E: 16.2

宁德时代

300750

1.9T

P/E: 25.6

贵州茅台

600519

1.8T

P/E: 20.1

中国银行

601988

1.8T

P/E: 7.3

中国人寿

601628

1.2T

P/E: 6.9

Financial Statements

Loading financials...

Open Advanced Charts

Full charting with technical indicators, candlestick, and more.

About 浙江医药

Ticker	600216
Exchange	SSE
Sector	证监会行业分类
Industry	C27医药制造业